首页> 美国卫生研究院文献>Translational Lung Cancer Research >From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules a summary of the 2015 Chinese-German Lung Cancer Expert Panel
【2h】

From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules a summary of the 2015 Chinese-German Lung Cancer Expert Panel

机译:从肺癌的诊断到治疗:CT检测到的肺结节的管理2015年中德肺癌专家小组会议摘要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The first Chinese-German Lung Cancer Expert Panel was held in November 2015 one day after the 7th Chinese-German Lung Cancer Forum, Shanghai. The intention of the meeting was to discuss strategies for the diagnosis and treatment of lung cancer within the context of lung cancer screening. Improved risk classification criteria and novel imaging approaches for screening populations are highly required as more than half of lung cancer cases are false positive during the initial screening round if the National Lung Screening Trial (NLST) demographic criteria [≥30 pack years (PY) of cigarettes, age ≥55 years] are applied. Moreover, if the NLST criteria are applied to the Chinese population a high number of lung cancer patients are not diagnosed due to non-smoking related risk factors in China. The primary goal in the evaluation of pulmonary nodules (PN) is to determine whether they are malignant or benign. Volumetric based screening concepts such as investigated in the Dutch-Belgian randomized lung cancer screening trial (NELSON) seem to achieve higher specificity. Chest CT is the best imaging technique to identify the origin and location of the nodule since 20% of suspected PN found on chest X-ray turn out to be non-pulmonary lesions. Moreover, novel state-of-the-art CT systems can reduce the radiation dose for lung cancer screening acquisitions down to a level of 0.1 mSv with improved image quality to novel reconstruction techniques and thus reduce concerns related to chest CT as the primary screening technology. The aim of the first part of this manuscript was to summarize the current status of novel diagnostic techniques used for lung cancer screening and minimally invasive treatment techniques for progressive PNs that were discussed during the first Chinese-German Lung Cancer. This part should serve as an educational part for the readership of the techniques that were discussed during the Expert Panel. The second part summarizes the consensus recommendations that were interdisciplinary discussed by the Expert Panel.
机译:在第七届中德肺癌论坛在上海举行的第二天,第一届中德肺癌专家小组会议于2015年11月举行。会议的目的是讨论在肺癌筛查范围内诊断和治疗肺癌的策略。如果国家肺癌筛查试验(NLST)的人口统计学标准[≥30包年(PY)为30岁以上],则在最初的筛查阶段中,超过一半的肺癌病例为假阳性,因此迫切需要改进风险分类标准和新颖的影像学方法来筛查人群。年龄≥55岁的香烟]。此外,如果将NLST标准应用于中国人群,则由于中国与吸烟无关的危险因素,很多肺癌患者未得到诊断。评估肺结节(PN)的主要目的是确定它们是恶性还是良性的。诸如在荷兰-比利时随机肺癌筛查试验(NELSON)中研究的基于体积的筛查概念似乎具有更高的特异性。胸部CT是鉴定结节起源和位置的最佳成像技术,因为在胸部X线检查中发现的20%疑似PN是非肺部病变。此外,新颖的CT系统可以将肺癌筛查采集的辐射剂量降低到0.1 mSv的水平,并且通过新颖的重建技术提高了图像质量,因此减少了将胸部CT作为主要筛查技术的担忧。本文第一部分的目的是概述在首批中德肺癌期间讨论的用于肺癌筛查的新型诊断技术和进行性PN的微创治疗技术的现状。此部分应作为教育性的部分,供读者阅读专家小组中讨论的技术。第二部分总结了专家小组跨学科讨论的共识性建议。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号